These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 27261683)
21. Early relapses, onset of progression, and late outcome in multiple sclerosis. Scalfari A; Neuhaus A; Daumer M; Deluca GC; Muraro PA; Ebers GC JAMA Neurol; 2013 Feb; 70(2):214-22. PubMed ID: 23407713 [TBL] [Abstract][Full Text] [Related]
22. Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks. Créange A; Debouverie M; Jaillon-Rivière V; Taithe F; Liban D; Moutereau A; Clavelou P; Defer G Mult Scler; 2009 Sep; 15(9):1085-91. PubMed ID: 19556312 [TBL] [Abstract][Full Text] [Related]
23. [Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses]. de Andrés C; Anaya F; Giménez-Roldán S Rev Neurol; 2000 Apr 1-15; 30(7):601-5. PubMed ID: 10859735 [TBL] [Abstract][Full Text] [Related]
24. Repository corticotropin injection improves quality metrics in an observational study of multiple sclerosis relapse. Kaplan J; Miller T; Baker M; Due B; Zhao E Neurodegener Dis Manag; 2021 Dec; 11(6):469-476. PubMed ID: 34860120 [TBL] [Abstract][Full Text] [Related]
25. Predictors of relapse rate in MS clinical trials. Held U; Heigenhauser L; Shang C; Kappos L; Polman C; Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520 [TBL] [Abstract][Full Text] [Related]
26. Corticosteroids in the treatment of multiple sclerosis. Myhr KM; Mellgren SI Acta Neurol Scand Suppl; 2009; (189):73-80. PubMed ID: 19566504 [TBL] [Abstract][Full Text] [Related]
29. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350 [TBL] [Abstract][Full Text] [Related]
30. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic plasma exchange in MS refractory relapses: Long-term outcome. Marrodan M; Crema S; Rubstein A; Alessandro L; Fernandez J; Correale J; Ysrraelit MC Mult Scler Relat Disord; 2021 Oct; 55():103168. PubMed ID: 34332460 [TBL] [Abstract][Full Text] [Related]
32. Severe relapse of multiple sclerosis during plasma exchange treatment. Matzke B; Metze C; Winkelmann A; Grossmann A; Hartung HP; Benecke R; Zettl UK Mult Scler; 2011 Jun; 17(6):759-62. PubMed ID: 21427132 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic management of severe relapses in multiple sclerosis. Bevan C; Gelfand JM Curr Treat Options Neurol; 2015 Apr; 17(4):345. PubMed ID: 25794777 [TBL] [Abstract][Full Text] [Related]
34. Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studies. Mäurer M; Comi G; Freedman MS; Kappos L; Olsson TP; Wolinsky JS; Miller AE; Dive-Pouletty C; Bozzi S; O'Connor PW Mult Scler Relat Disord; 2016 May; 7():33-40. PubMed ID: 27237754 [TBL] [Abstract][Full Text] [Related]
36. Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients. Le Page E; Leray E; Taurin G; Coustans M; Chaperon J; Morrissey SP; Edan G J Neurol Neurosurg Psychiatry; 2008 Jan; 79(1):52-6. PubMed ID: 17846110 [TBL] [Abstract][Full Text] [Related]
37. [Change of interleukin-4 and interleukin-12 levels after therapy of multiple sclerosis relapse with methylprednisolone]. Bartosik-Psujek H; Magryś A; Montewka-Kozioł M; Stelmasiak Z Neurol Neurochir Pol; 2005; 39(3):207-12. PubMed ID: 15981158 [TBL] [Abstract][Full Text] [Related]
38. Relapses in multiple sclerosis are age- and time-dependent. Tremlett H; Zhao Y; Joseph J; Devonshire V; J Neurol Neurosurg Psychiatry; 2008 Dec; 79(12):1368-74. PubMed ID: 18535026 [TBL] [Abstract][Full Text] [Related]
39. [Differential influence of immune therapy on relapses and progression in multiple sclerosis: interpretation and therapeutic consequences]. Kornhuber ME; Presek P; Zierz S Fortschr Neurol Psychiatr; 2005 Mar; 73(3):143-9. PubMed ID: 15747223 [TBL] [Abstract][Full Text] [Related]
40. Impact of multiple sclerosis relapse: The NARCOMS participant perspective. Nickerson M; Cofield SS; Tyry T; Salter AR; Cutter GR; Marrie RA Mult Scler Relat Disord; 2015 May; 4(3):234-40. PubMed ID: 26008940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]